When is it safe to end COVID-19 quarantine (isolation) after symptom onset, being fever‑free for 24 hours without antipyretics, and having improving symptoms?

When to End COVID-19 Isolation

For most patients with COVID-19, isolation can safely end after at least 10 days from symptom onset, provided they have been fever-free for at least 24 hours (without antipyretics) and other symptoms are improving. 1, 2

Symptom-Based Strategy (Recommended for Most Patients)

The symptom-based approach is the preferred strategy for ending isolation, as it reflects the low likelihood of transmission from clinically recovering individuals over time 1. All three criteria must be met:

1. ≥10 days have passed since symptom onset
2. ≥24 hours (some guidelines specify ≥72 hours) fever-free without antipyretics
3. Clinically meaningful improvement in respiratory symptoms (cough, shortness of breath)

Rationale for This Approach

Research demonstrates that most adults have replication-competent SARS-CoV-2 for 10-14 days after symptom onset 3. Studies show that SARS-CoV-2 infectivity rapidly decreases after symptom onset to near-zero after approximately 10 days in mild-moderately ill patients 4. The risk of releasing an infectious individual using the 10-day criterion is estimated at only 0-6.6% 5.

Special Populations Requiring Extended Isolation

Severely or Critically Ill Patients

• Extend isolation to ≥15 days from symptom onset 4
• These patients may shed viable virus for longer periods

Immunocompromised Patients

• Extend isolation to ≥15-20 days from symptom onset 4
• Consider a test-based strategy (see below)
• Requires multidisciplinary evaluation 6
• The longest documented interval with replication-competent virus is 20 days from symptom onset 4

Hospitalized Patients

Some guidelines recommend isolation for ≥14 days from first positive test for hospitalized asymptomatic patients 6

Test-Based Strategy (When Needed)

A test-based approach may be required for immunocompromised patients, healthcare workers, or those in high-risk settings 1. This requires:

1. All symptom-based criteria met (as above)
2. Two consecutive negative RT-PCR or NAAT tests collected ≥24 hours apart 1, 6

Important Testing Caveats

Do not rely on RT-PCR alone for ending isolation decisions 1. Viral RNA can remain detectable for weeks to months after clinical recovery without representing replication-competent virus 4. In one study, half of participants still had detectable viral RNA 21-30 days after symptom onset, despite being non-infectious 3.

Nucleocapsid (N) antigen testing is superior to RT-PCR for predicting infectiousness. N antigen strongly correlates with culture positivity (relative risk 7.61-7.66) and is a better biomarker than viral RNA or symptoms for determining infectiousness within 14 days of symptom onset 3, 7.

Updated Guidance for Shorter Isolation

The most recent ACC guideline (2022) references CDC guidance of ≥5 days of self-isolation from symptom onset or positive test 8. However, this shorter duration should be applied cautiously:

• After 5-9 days, 54.3% of persons still tested positive on antigen testing 7
• Risk factors for prolonged positivity include: symptomatic infection, lack of prior infection, and unvaccinated status 7
• If using 5-day isolation, a negative antigen test should be required before ending isolation 7

Common Pitfalls to Avoid

1. Don't use a single negative RT-PCR test to rule out infectiousness - false negatives occur, especially with nasopharyngeal swabs 6

2. Don't discharge patients on day 5 without negative antigen testing - over half remain infectious 7

3. Don't ignore steroid use - patients on corticosteroids may have prolonged viral shedding and require extended isolation 9

4. Don't forget about transmission precautions post-isolation - patients should wear well-fitting masks around others for 10 days after infection onset, even if isolation ends at 5 days 7